Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.04M Buy
7,782
+35
+0.5% +$8.97K 0.06% 110
2026
Q2
$1.95M Buy
+7,747
New +$1.67M 0.06% 112

Other funds holding ABBV

Sprott's ABBV Position: Q3 2026 in Review

Sprott increased its AbbVie (ABBV) stake by 0.45% in Q3 2026, buying an estimated $8.97K and bringing the position to 7,782 shares worth $2.04M. The position accounts for 0.06% of the portfolio, ranked #110.

Sprott first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sprott held 7,782 shares of AbbVie worth $2.04M as of Q3 2026.
  • Sprott bought 35 AbbVie shares in Q3 2026, an estimated $8.97K.
  • AbbVie made up 0.06% of Sprott's portfolio in Q3 2026, its #110 holding.
  • Sprott first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.